In Silico Studies of Crystal Structure of HCV NS5B Polymerase and Inhibitor Complex

被引:0
|
作者
Tiwari, Gargi [1 ]
Pandey, Vishnudatt [1 ]
Tiwari, Rakesh Kumar [1 ]
Ojha, Rajendra Prasad [1 ]
机构
[1] DDU Gorakhpur Univ, Dept Phys, Biophys Unit, Gorakhpur, Uttar Pradesh, India
关键词
QM/MM Molecular Dynamics Simulations; HCV; Hydrogen Bonding; AB-INITIO CALCULATIONS; MOLECULAR-DYNAMICS SIMULATIONS; ZEOLITE CATALYSTS; SYSTEMS; ALUMINOSILICATES; STABILIZATION; FIELD; ION; RNA;
D O I
10.1016/j.matpr.2018.05.029
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Quantum mechanics/molecular mechanics (QM/MM) and molecular dynamics simulations were performed to study the hydrogen bonding and polar interactions of an inhibitor namely 2-{[(5-bromothiophen-2-yl) sulfonyl] amino}- 4-chlorobenzoic acid with HCV NS5B polymerase. Using the initial poses, our aim is to identify the minimum energy positions and calculate binding affinities of inhibitor to HCV. Results suggest that the accuracy of binding affinity prediction can be significantly affected by the proper treatment of the hydrogen bonding and polar interactions. Using this protocol, we successfully identified important poses of low RMSD with respect to crystallographic structure from the initially docked poses. This work shows that the most important energetic component contributing to binding for this particular protein-ligand system is the conformational energy. In addition, formation of hydrogen bonds can produce favorable van der Waals interactions with some important residues. This systematic study can provide guidance for the choice of QM/MM MD methods and design of new inhibitors targeting HCV. (c) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:15431 / 15438
页数:8
相关论文
共 50 条
  • [41] NS5B polymerase inhibitors in phase II clinical trials for HCV infection
    Borgia, Guglielmo
    Maraolo, Alberto Enrico
    Nappa, Salvatore
    Gentile, Ivan
    Buonomo, Antonio Riccardo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (03) : 243 - 250
  • [42] IMPACT OF ANTIRETROVIRAL THERAPY ON THE VARIABILITY OF THE HCV NS5B POLYMERASE IN HIV/HCV COINFECTED PATIENTS
    Plaza, Z.
    Soriano, V.
    Bar-Magen, T.
    Gonzalez, M. M.
    Di Lello, F.
    Macias, J.
    Labarga, P.
    Pineda, J. A.
    Poveda, E.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S486 - S486
  • [43] Pyridine Carboxamides: Potent Palm Site Inhibitors of HCV NS5B Polymerase
    Cheng, Cliff C.
    Huang, Xiaohua
    Shipps, Gerald W., Jr.
    Wang, Yu-Sen
    Wyss, Daniel F.
    Soucy, Kyle A.
    Jiang, Chuan-kui
    Agrawal, Sony
    Ferrari, Eric
    He, Zhiqing
    Huang, H-C
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (09): : 466 - 471
  • [44] Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection
    Beaulieu, Pierre L.
    IDRUGS, 2010, 13 (12) : 938 - 948
  • [45] Classification of HCV NS5B Polymerase Inhibitors Using Support Vector Machine
    Wang, Maolin
    Wang, Kai
    Yan, Aixia
    Yu, Changyuan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (04) : 4033 - 4047
  • [46] Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors
    Golub, Andriy G.
    Gurukumar, K. R.
    Basu, Amartya
    Bdzhola, Volodymyr G.
    Bilokin, Yaroslav
    Yarmoluk, Sergiy M.
    Lee, Jin-Ching
    Talele, Tanaji T.
    Nichols, Daniel B.
    Kaushik-Basu, Neerja
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 58 : 258 - 264
  • [47] Design, Molecular Modelling Studies of Specific Targeted Candidate Inhibitors of HCV NS5B RNA Polymerase
    Selvam, P.
    Chandramohan, M.
    Pranitha, J.
    Prabhu, N. Saravanan
    Kumar, Muthuvels Suresh
    ANTIVIRAL RESEARCH, 2009, 82 (02) : A31 - A32
  • [48] Further SAR studies on novel small molecule inhibitors of the hepatitis C (HCV) NS5B polymerase
    Reddy, TJ
    Chan, L
    Turcotte, N
    Proulx, M
    Pereira, OZ
    Das, SK
    Siddiqui, A
    Wang, WY
    Poisson, C
    Yannopoulos, CG
    Bilimoria, D
    L'Heureux, L
    Alaoui, HMA
    Nguyen-Ba, N
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) : 3341 - 3344
  • [49] Formal Synthesis of Hepatitis C Virus NS5B Polymerase Inhibitor
    Noro, Takahiro
    Okano, Kentaro
    Tokuyama, Hidetoshi
    SYNLETT, 2013, 24 (16) : 2143 - 2147
  • [50] Molecular Modeling Comparison of the Performance of NS5b Polymerase Inhibitor (PSI-7977) on Prevalent HCV Genotypes
    Abdo A. Elfiky
    Wael M. Elshemey
    Wissam A. Gawad
    Omar S. Desoky
    The Protein Journal, 2013, 32 : 75 - 80